Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 19 unusual trades.
Delving into the details, we found 26% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $762,532, and 5 were calls, valued at $755,304.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $290.0 to $340.0 for Amgen over the last 3 months.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Amgen's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Amgen's substantial trades, within a strike price spectrum from $290.0 to $340.0 over the preceding 30 days.
Amgen Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
About Amgen
Following our analysis of the options activities associated with Amgen, we pivot to a closer look at the company's own performance.
Present Market Standing of Amgen
- Trading volume stands at 1,441,651, with AMGN's price down by -3.31%, positioned at $303.98.
- RSI indicators show the stock to be may be approaching oversold.
- Earnings announcement expected in 37 days.
Expert Opinions on Amgen
1 market experts have recently issued ratings for this stock, with a consensus target price of $294.0.
Turn $1000 into $1270 in just 20 days?
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Amgen, Benzinga Pro gives you real-time options trades alerts.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

